Arkstone Introduces Cost Information to Enhance Antimicrobial Prescribing Transparency

Arkstone Enhances OneChoice with Drug Cost Information



In a noteworthy move towards transparency in antimicrobial prescribing, Arkstone, a leading authority in laboratory infectious disease guidance and antimicrobial stewardship, has announced the introduction of real-time drug cost information within its OneChoice platform. This enhancement is set to transform the way physicians approach antimicrobial treatment decisions, providing greater financial clarity alongside clinical efficacy and safety data.

The Importance of Cost Considerations


Effective antimicrobial prescribing necessitates a careful balancing act. While clinical effectiveness remains a paramount concern, the cost of treatments can significantly influence patient adherence and overall healthcare expenses. With the ever-increasing costs associated with healthcare, having immediate access to price information is crucial. Physicians often find themselves silhouetted by the dual pressure of ensuring therapeutic effectiveness while also considering the financial implications of the medications they prescribe.

The integration of drug cost analysis into OneChoice empowers physicians to navigate these challenges more adeptly. They can now visualize cost alongside efficacy and safety metrics directly within the OneChoice reports—eliminating the need for time-consuming external price checks and ensuring that treatment options are not only clinically sound but also financially viable.

A Holistic Approach to Treatment Decisions


Dr. Ari Frenkel, Chief Science Officer at Arkstone, emphasized the importance of this enhancement, stating, "Adding drug cost information to OneChoice reinforces Arkstone's mission of advancing antimicrobial stewardship and patient-centered care. With rising healthcare costs, physicians need access to transparent drug pricing information. This integration ensures that every prescription aligns with both medical efficacy and financial responsibility."

The new drug cost analysis tool offers key features aimed at streamlining the prescribing process:
  • - Transparent Pricing Insights: This feature presents physicians with vital pricing data, supporting more cost-aware prescribing practices.
  • - Enhanced Decision-Making: Clinicians can evaluate cost insights alongside clinical data—an approach designed to facilitate a more comprehensive treatment strategy.
  • - Seamless OneChoice Integration: The cost information is readily available within OneChoice reports, both in the standard PDF format and in the interactive OneChoice Plus, ensuring an efficient workflow for healthcare providers.

Driving Efficiency in Healthcare


Dave Gross, Arkstone's Chief Technology Officer, remarked on the often underappreciated role of cost in selection processes. "Cost is often an overlooked factor in antimicrobial selection, yet it plays a crucial role in patient adherence and overall healthcare efficiency. By equipping physicians with real-time cost data, we enable smarter prescribing decisions that ultimately benefit both patients and providers."

With these enhancements, Arkstone reinforces its commitment to precision-driven antimicrobial stewardship. The inclusion of drug cost information not only ensures the appropriateness of medical choices but also promotes economic responsibility among healthcare providers. This initiative contributes to smarter, safer prescribing practices that aim to create a more sustainable healthcare environment.

About Arkstone


Arkstone is recognized globally as a leader in infectious disease clinical guidance and antimicrobial stewardship. Through its innovative AI-driven solutions, known as Antimicrobial Intelligence, the organization delivers evidence-based, patient-specific recommendations aimed at combating antibiotic misuse and curtailing antimicrobial resistance. Through this commitment, Arkstone is dedicated to supporting clinicians in making informed prescribing decisions that are not only beneficial to individual patients but also to the healthcare system at large.

For more information about Arkstone and its initiatives, visit www.arkstone.ai or reach out via email at info@arkstone.ai.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.